Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-18 | "Dr. Olukotun’s significant executive leadership experience was instrumental in his selection as a member of our Board." |
| 2019-12-13 | “Adeoye Olukotun” |
| 2020-03-30 | “Dr. Olukotun has been the Chief Executive Officer of CR Strategies, LLC… and was the Chief Executive Officer of EpiGen Pharmaceuticals…” |
| 2020-05-15 | "Adeoye Olukotun" |
| 2021-02-11 | "Adeoye Olukotun" appears in the security ownership table under "by each of our officers and directors" |
| 2021-03-31 | "Dr. Olukotun’s extensive medical background and experience in the pharmaceutical industry was instrumental in his selection as a member of our Board." |
| 2021-12-23 | "Adeoye Olukotun" |
| 2022-03-18 | "Dr. Olukotun’s extensive medical background and experience in the pharmaceutical industry was instrumental in his selection as a member of our Board." |
| 2022-07-05 | "Adeoye Olukotun" |
| 2022-11-07 | "Adeoye Olukotun" |
| 2023-03-17 | “Dr. Olukotun’s extensive medical background and experience in the pharmaceutical industry was instrumental in his selection as a member of our Board.” |
| 2023-12-26 | "Adeoye Olukotun" |
| 2024-01-08 | "Adeoye Olukotun" |
| 2024-04-15 | "Dr. Olukotun’s extensive medical background and experience in the pharmaceutical industry was instrumental in his selection as a member of our Board." |
| 2024-09-23 | "Adeoye Olukotun" |
| 2025-03-31 | "Dr. Olukotun’s extensive medical background and experience in the pharmaceutical industry was instrumental in his selection as a member of our Board." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04